دورية أكاديمية

Formulation, characterization and evaluation of gelatin-syringic acid/zinc oxide nanocomposite for its effective anticancer, antioxidant and anti-inflammatory activities

التفاصيل البيبلوغرافية
العنوان: Formulation, characterization and evaluation of gelatin-syringic acid/zinc oxide nanocomposite for its effective anticancer, antioxidant and anti-inflammatory activities
المؤلفون: M. Lavanya, Rajapandiyan Krishnamoorthy, Mohammad A. Alshuniaber, Salim Manoharadas, Chella Perumal Palanisamy, Vishnu Priya Veeraraghavan, Selvaraj Jayaraman, Ponnulakshmi Rajagopal, Ramakrishnan Padmini
المصدر: Journal of King Saud University: Science, Vol 35, Iss 8, Pp 102909- (2023)
بيانات النشر: Elsevier, 2023.
سنة النشر: 2023
المجموعة: LCC:Science (General)
مصطلحات موضوعية: Zinc oxide nanoparticle, Syringic acid, Gelatin, Hep G2 cell line, Antioxidant, Anti-inflammatory, Science (General), Q1-390
الوصف: Background: Hepatocellular carcinoma (HCC) is the most typical form of liver cancer. Apart from modern therapies, various natural chemical constituents have been tested for the treatment of HCC. However, the usage of the latter has declined due to their low bioavailability and stability. Objectives: Considering the above drawback’s, in this study, we describe a gelatin-syringic acid/ zinc oxide (ZnO) nanocomposite for liver cancer treatment, which showed antioxidant, anti-inflammatory and anticancer activities. Methods: The hydrothermal method was used to synthesize ZnO nanoparticle and it was encapsulated with gelatin-syringic acid by coacervation technique. The nanocomposites were characterized by UV spec, FTIR, SEM, XRD, EDX, and DLS. The drug release profile of nanocomposite was studied by dialysis bag method, which exhibits a sustained drug release. Results: The antioxidant ability of nano-composite was studied by performing an ABTS and DPPH assay and the IC50 was recorded as 76.5 and 47.63 µg/mL, respectively. The anti-inflammatory potential was studied by assessing the ability of nanocomposite on denaturation of protein and the results exhibited a dose-dependent inhibition. The acute toxicity of nanocomposite tested on zebrafish liver and heart showed that it is non-toxic. Moreover, the nanocomposite inhibits the Hep G2 cell viability with an increasing concentration and it increases oxidative stress caused by the mitochondrial damage, which leads to cell death. Conclusion: Based on the findings of the present study, gelatin-syringic acid/ZnO nanocomposite has been shown to possess antioxidant, and anti-inflammatory properties, and thus can be used against HCC.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1018-3647
Relation: http://www.sciencedirect.com/science/article/pii/S1018364723003713; https://doaj.org/toc/1018-3647
DOI: 10.1016/j.jksus.2023.102909
URL الوصول: https://doaj.org/article/192256298b43467ba72baa89645b5848
رقم الأكسشن: edsdoj.192256298b43467ba72baa89645b5848
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:10183647
DOI:10.1016/j.jksus.2023.102909